Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries | Zendy

Lúcia Helena de Oliveira | Zendy; Kayoko Shioda | Zendy; María Teresa Valenzuela | Zendy; Cara Bess Janusz | Zendy; Analía Rearte | Zendy; Alyssa N. Sbarra | Zendy; Joshua L. Warren | Zendy; Cristiana M. Toscano | Zendy; Daniel M. Weinberger | Zendy

Open Access

Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries

Author(s) -

Lúcia Helena de Oliveira,

Kayoko Shioda,

María Teresa Valenzuela,

Cara Bess Janusz,

Analía Rearte,

Alyssa N. Sbarra,

Joshua L. Warren,

Cristiana M. Toscano,

Daniel M. Weinberger

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa614

Subject(s) - medicine , pneumonia , incidence (geometry) , demography , population , pneumococcal pneumonia , latin americans , mortality rate , pneumococcal conjugate vaccine , pediatrics , environmental health , streptococcus pneumoniae , antibiotics , linguistics , philosophy , physics , microbiology and biotechnology , sociology , optics , biology

Pneumococcal conjugate vaccines (PCVs) are recommended for use in pediatric immunization programs worldwide. Few data are available on their effect against mortality. We present a multicountry evaluation of the population-level impact of PCVs against death due to pneumonia in children < 5 years of age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research